Sveikatos mokymų centras, UAB - financials and debts

Company age: 3 y. 6 mo.

Update

Sveikatos mokymų centras - Company finances

EUR
2023
From: 2023-03-31
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 10,272 49,295 105,299
Profit before tax 2,615 4,934 18,061
Net profit 2,615 4,680 16,984
Equity 5,115 9,795 26,779
Liabilities 243 1,330 2,058
Non-current assets 1,623 2,465 1,528
Current assets 3,735 8,660 27,309
Total assets 5,358 11,125 28,837
Taxes paid
STI taxes 552 3,578 5,868
Financial indicators
Revenue change y/y - +379.9% +113.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 48.8% 42.1% 58.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 51.1% 47.8% 63.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 25.5% 9.5% 16.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 25.5% 10.0% 17.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.1 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 10,272 49,295 66,506

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Sveikatos mokymų centras - Social security debts

The company had no debts to Sodra

Sveikatos mokymų centras - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Sveikatos mokymu centras, UAB (code 306286305) is a Private Limited Liability Company operating in other education n.e.c. In the latest financial year, 2025, revenue reached €105.3K, up 113.6% year on year after €49.3K in 2024 and €10.3K in 2023. Net profit rose to €17.0K in 2025 from €4.7K in 2024 and €2.6K in 2023, showing a clear multi-year expansion in both turnover and earnings. The profit margin improved to 16.1% in 2025, compared with 9.5% in 2024, although it remained below the 25.5% recorded in 2023. At year-end 2025, total assets amounted to €28.8K, equity was €26.8K and liabilities were €2.1K. The company therefore remained strongly equity financed, with an equity ratio of 92.9% and debt-to-equity of 0.08. Return on equity stood at 63.4% and return on assets at 58.9%, reflecting efficient use of the balance sheet. Revenue per employee was €105.3K and profit per employee €17.0K.